https://www.selleckchem.com/products/cc-930.html
7±0.6% vs 6.8±0.7%, =0.0004) but increased significantly after FK treatment (3.7±0.6% vs 7.1±0.8%, =0.0039). Our data suggest that tacrolimus is a salvage treatment for patients with NSAA that is refractory or intolerant to CsA. Our data suggest that tacrolimus is a salvage treatment for patients with NSAA that is refractory or intolerant to CsA. To determine the spherical aberration, pupil size, and other key refractive and topographic parameters in a large cohort of Egyptian cataract surgery candidates, and to investigate any existent
Like
Comment
Share
